First off, thank you to my wonderful subscribers. I do this all for you! My goal is to give you education and break down the longevity medicine movement in a fashion that will get you to A Life Well Lived! Please share this with your friends, family and patients!
Next week, I’ll be speaking at the Longevity Summit in Cannes, France. It’s not just another conference. It’s a focused gathering of physicians, scientists, entrepreneurs, and global health leaders reshaping how we approach aging. This summit reflects a tectonic shift away from symptom-focused medicine toward data-backed, systems-driven longevity care.
I’ll be there as a physician, educator, and one of the founding members of the Longevity Docs community—a group of over 400 international physicians aligned around a core idea: we need better data, tighter protocols, and a unified language if we’re going to make longevity medicine both effective and scalable.
This post recaps key points I cover in my full video transcript for those short on time. You’ll find a snapshot of what I’ll be doing in Cannes, why it matters, and what’s next for this emerging field.
What We’re Covering in Cannes
The centrality of data in longevity medicine
The field is evolving beyond hype. We’re seeing the rise of real-world registries, starting with orthobiologics, now expanding into GLP-1s, peptide therapeutics, and even gene therapy. I’m working closely with colleagues like Dr. David Luu to build robust longevity registries that track outcomes across interventions. This is how obesity medicine matured. Longevity medicine must follow the same path.
Functional medicine meets cell biology
I trained in genetics and molecular biology, and for years I’ve taught pathology and anatomy. When functional medicine works, it’s because it speaks the language of the cell. In Cannes, we’ll discuss how to bring functional frameworks into alignment with molecular data, using labs, biomarkers, and mechanistic insight to guide treatment.
Regenerative medicine and the GLP-1 connection
GLP-1 medications are not just weight-loss tools. They reduce neuroinflammation, affect senescent cell burden, and—little known fact—support cartilage health. As someone active in orthobiologics, I’ve seen these effects firsthand. In Cannes, I’ll join leaders like Dr Kuo, Dr. Hussein, and others to dig into GLP-1s as core longevity tools.
Get a Copy of My Book: Weight Loss Secrets Revealed: Your Ultimate Guide to GLP-1 Medications and read a bit right here. Let me know what you think!
Peptides, cellular optimization, and chronic disease
Peptides are everywhere right now, and for good reason. When tracked correctly, they deliver real outcomes in conditions like long COVID, Lyme disease, and immune dysfunction. We’ll look at what works, what’s marketing, and what protocols actually hold up in the real world.
Listen to Dr Yurth talk about Peptides Here
Gene therapy as present-tense medicine
Dr. Sewell will be discussing gene therapy not as a future concept but as something happening now in controlled, monitored, international settings. This includes protocols for patients seeking healthy lifespan extension—not just disease reversal.
Hormones and the foundational role of measurement
Dr. Amy Killen will present a comprehensive hormone framework. We’ll tie this into broader themes of measuring what matters: mitochondria, NAD+, inflammation, stem cell markers. All of this underpins the coaching work I’m doing through the Founder’s Club, where we train physicians to think in systems.
Want to follow the Cannes Longevity Docs Summit in Real Time? Become a subscriber!
Controversies on rapamycin, metformin, dasatinib, NAD+
These debates are real. And necessary. I’ll be weighing in on the misinterpretation of dasatinib data, the truth about NAD side effects, and how we integrate these interventions into personalized care. The media is often ahead of the data—or worse, misrepresents it. That stops here.
Longevity Science Deserves Nuance, Not Blanket Dismissals
In a recent YouTube discussion, Dr. Eric Topol and Dr. Mike Varshavski (Doctor Mike) provided a critique of longevity medicine, raising several possibly valid points but also making definitive statem…
Skin as a diagnostic tool for systemic aging
L’Oreal’s Chief Innovation Officer will present on how skin reflects biological age. We’re finally seeing dermatology and systems biology converge. It’s about time.
Urban design and healthy aging
We’ll hear from the NY Commissioner on Aging and the health systems designer for NEOM, the futuristic city in Saudi Arabia. Their mission: how do you build an environment for long life? The answers are complex, but essential.
Scaling longevity care without losing clinical integrity
Many physicians are now asking how to build and grow practices rooted in evidence, not just aesthetics. We’ll look at AI, automation, and clinical infrastructure with insights from Healthy Up, Next Health, and other leaders working to democratize this field responsibly.
Why This Matters
If we want to move beyond claims and marketing into real, accountable longevity care, we must anchor the field in data, mechanism, and collaboration. That is what Cannes represents. It is where regenerative medicine, functional frameworks, omics data, and biotech innovation converge—not in theory, but in real clinical application.
This is the future of medicine. Not just lifespan, but healthspan. Not just living longer, but living better.
I’ll be reporting back with detailed notes, protocol reviews, and implementation strategies for those of you building your own longevity plans…..or guiding others through theirs.
Until then, stay focused on the fundamentals:
Good sun, at the right time.
Real connection with family and friends.
Deep, consistent sleep.
Those still matter more than most people realize.
To A Life Well Lived,
— Dr. M
Share this post